Advanced search
Publication Cover
Hematology Volume 21, 2016 - Issue 5
Submit an article Journal homepage
1,656
Views
7
CrossRef citations to date
0
Altmetric
Hematological Malignancy

Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience

Xin ZhouDepartment of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China
,
Jun XiaDepartment of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China
,
Jingjue MaoDepartment of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China
,
Feng ChengDepartment of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China
,
Xifeng QianDepartment of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China
&
Hongfeng GuoDepartment of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, ChinaCorrespondence[email protected]
Pages 280-286 | Published online: 01 Mar 2016

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tilman Hans Steinmetz, Moushmi Singh, Andrea Lebioda, Leah Fink, Martina Schoehl, Achim Rieth, Sebastian Gonzalez-McQuire & Monika Engelhardt. (2021) Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany. Journal of Medical Economics 24:1, pages 114-122.
Read now
Hongfu Cai, Longfeng Zhang, Na Li, Bin Zheng & Maobai Liu. (2019) Cost-effectiveness analysis on binary/triple therapy on the basis of ixazomib or bortezomib for refractory or relapsed multiple myeloma. Leukemia & Lymphoma 60:12, pages 2951-2959.
Read now
Sebastian Gonzalez-McQuire, Kwee Yong, Henri Leleu, Francesco S. Mennini, Alain Flinois, Carlotta Gazzola, Paul Schoen, Marco Campioni, Lucy DeCosta & Leah Fink. (2018) Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy. Journal of Medical Economics 21:5, pages 450-467.
Read now

Articles from other publishers (4)

Zixuan He, Xianqin Huang, Dingyi Chen, Guoan Wang, Yuezhen Zhu, Huangqianyu Li, Sheng Han, Luwen Shi & Xiaodong Guan. (2023) Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review. BMJ Global Health 8:11, pages e012780.
Crossref
Diana Beatriz Bayani, Yihao Clement Lin, Melissa G. Ooi, Allison Ching Yee Tso & Hwee Lin Wee. (2023) Real‐world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore. eJHaem 4:4, pages 1013-1018.
Crossref
Enrique M. Ocio, Carmen Montes-Gaisán, Gabriela Bustamante, Sebastián Garzón, Esther González, Ernesto Pérez-Persona, Verónica González-Calle, Maialen Sirvent, José M. Arguiñano, Yolanda González, Rafael Ríos, Dunia de Miguel, Marta Grande, Alonso Fernández-Nistal, Andrea Naves & Laura Rosiñol. (2023) Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study. Clinical Lymphoma Myeloma and Leukemia.
Crossref
David MerolaCandice YongStephen J. NogaKenneth M. Shermock. (2018) Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable Chemotherapy. Journal of Managed Care & Specialty Pharmacy 24:10, pages 1019-1026.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.